What is Vista Pharmaceuticals share price return in the past 10 years?

Vista Pharmaceuticals Ltd share price has declined -5.1% annually (CAGR) over the past ten years.

What is the P/E ratio of Vista Pharmaceuticals?

The latest standalone P/E ratio of Vista Pharmaceuticals as of 30-Apr-2025 is 0.00.

What is the P/B ratio of Vista Pharmaceuticals?

The latest standalone P/B ratio of Vista Pharmaceuticals as of 30-Apr-2025 is 1.37.

What is the 52-week high and low of Vista Pharmaceuticals?

The 52-week high of Vista Pharmaceuticals is Rs. 16.59 and the 52-week low is Rs. 9.10.

Vista Pharmaceuticals Ltd - Stock Valuation and Financial Performance

Name: Vista Pharmaceuticals
Brand: Vista Pharmaceuticals

BSE: 524711 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Vista Pharma Share Price

₹10.85 -0.01 -0.09%
as on 30-Apr'25 16:59

DeciZen - make an informed investing decision on Vista Pharma

Based on:

Data

M-Cap below 100cr DeciZen not available

Vista Pharmaceuticals stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

63.2 Cr.

52-wk low:

9.1

52-wk high:

16.6

Is Vista Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Vista Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vista Pharmaceuticals Ltd is a below average quality company.

2. Is Vista Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Vista Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Vista Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vista Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vista Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	14.2%	9.6%	8.9%	12.4%	6.3%	-5.2%	-5.1%	-3.8%	-9.6%	-8.3%	-
Value Creation Index ⓘ	0.0	-0.3	-0.4	-0.1	-0.6	-1.4	-1.4	-1.3	-1.7	-1.6	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	13.8	15.4	24.2	28.9	31.1	22.8	1.3	0.4	1	10.3	10
Sales YoY Gr.	-	11.9%	57.2%	19.6%	7.4%	-26.8%	-94.4%	-69.3%	156.4%	929%	-
Adj EPS ⓘ	0.1	0.4	0.5	0.7	0	-1.3	-0.6	-0.2	-1.5	-1	-0.5
YoY Gr.	-	218.2%	34.3%	48.9%	-100%	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	4.2	4.5	6.3	9	11	9.8	8.9	9.6	8.1	7.6	7.9
Adj Net Profit ⓘ	1.4	0.9	1.3	2	0	-3.8	-2	-0.9	-5.6	-4.5	-3
Cash Flow from Ops. ⓘ	-3.5	-2.5	2.6	-4.6	3.3	0.8	-6.8	-1	-1.7	-4.9	-
Debt/CF from Ops. ⓘ	-1.1	-3.2	4.4	-2.4	3.4	19.3	-1.6	-12.6	-5.8	-1.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-3.2%	-19.8%	100.9%	929%
Adj EPS ⓘ	-227.1%	NA	NA	NA
BVPSⓘ	6.8%	-7.2%	-5.4%	-7%
Share Price	-5.1%	7.3%	7.1%	-22.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	14.5	8	9	8.4	0	-11.6	-6.4	-2.5	-15.4	-11.6	-6.8
Op. Profit Mgn % ⓘ	20.3	17.7	12.6	18.5	4	-21.1	-136.6	-306.8	-386.9	-33.4	-28.7
Net Profit Mgn % ⓘ	10.3	5.6	5.2	7	0	-16.6	-158.6	-215.1	-552.7	-43.4	-30.9
Debt to Equity ⓘ	0.4	0.7	0.7	0.4	0.3	0.5	0.3	0.4	0.3	0.2	-
Working Cap Days ⓘ	189	332	270	290	287	351	6,408	21,738	8,671	878	426
Cash Conv. Cycle ⓘ	-17	95	52	59	153	249	3,977	13,580	6,495	492	214

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 100.85%

Return on Equity is Poor

Sales growth is not so good in last 4 quarters at 3.39%

Latest Financials - Vista Pharmaceuticals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0.5	-
TTM Sales (₹ Cr.)	10	-
BVPS (₹.) ⓘ	7.9	-
Reserves (₹ Cr.) ⓘ	35	-
P/BV ⓘ	1.37	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	9.10 / 16.59
All Time Low / High (₹)	0.08 / 56.15
Market Cap (₹ Cr.)	63.2
Equity (₹ Cr.)	11.6
Face Value (₹)	2
Industry PE ⓘ	39.6

Management X-Ray of Vista Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Vista Pharma

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of Vista Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	13.75	15.38	24.18	28.92	31.07	22.76	1.27	0.39	1	10.29
Operating Expenses ⓘ	11.04	12.78	21.13	23.58	29.84	27.56	3	1.66	5.32	13.84
Manufacturing Costs	1.62	1.18	0.93	1.63	0.84	1.85	0.42	0.29	0.38	1.05
Material Costs	7.37	9.57	16.10	15.96	25.41	22.97	0.73	0.37	2.83	8.89
Employee Cost	0.69	0.81	0.70	0.87	1.18	1.31	1.15	0.57	0.51	1.79
Other Costs ⓘ	1.35	1.22	3.40	5.11	2.40	1.43	0.69	0.43	1.60	2.10
Operating Profit ⓘ	2.71	2.60	3.06	5.34	1.24	-4.80	-1.73	-1.27	-4.32	-3.55
Operating Profit Margin (%)	19.7%	16.9%	12.6%	18.5%	4.0%	-21.1%	-136.0%	-321.0%	-430.0%	-34.5%
Other Income ⓘ	0.01	0.02	0.06	0.40	2.95	3.75	0.20	0.17	0.40	0.33
Interest ⓘ	0.41	0.77	0.88	1.57	1.67	1.54	1.55	0.90	1.34	1.24
Depreciation ⓘ	1.05	1.02	1.02	1.34	1.36	1.35	0.73	0.62	0.62	0.72
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	1.26	0.84	1.22	2.83	1.15	-3.94	-3.81	-2.62	-5.88	-5.18
Tax ⓘ	-0.11	0.06	-0.02	0.64	0.21	-0.26	-1.80	-1.73	-0.21	-0.67
Profit After Tax	1.36	0.77	1.25	2.19	0.94	-3.68	-2.01	-0.89	-5.66	-4.51
PAT Margin (%)	9.9%	5.0%	5.2%	7.6%	3.0%	-16.2%	-158.0%	-225.0%	-564.0%	-43.9%
Adjusted EPS (₹)	0.5	0.3	0.5	0.8	0.3	-1.2	-0.6	-0.2	-1.5	-1.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	10.44	11.21	16.61	26.29	33.32	29.64	32.84	35.45	30.55	35.65
Share Capital ⓘ	5	5	5.31	5.83	6.07	6.07	7.36	7.36	7.51	9.43
Reserves ⓘ	5.44	6.21	11.29	20.46	27.25	23.57	25.49	28.09	23.04	26.22
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	4.04	7.88	11.33	11.06	11.17	15.47	10.71	12.55	9.96	7.96
Long Term Debt	0	7.88	6.03	5.88	5.96	5.51	8.69	7.43	5.18	2.93
Short Term Debt	4.04	0	5.30	5.18	5.21	9.96	2.02	5.13	4.78	5.03
Trade Payables	7.75	6.55	12.93	9.13	5.25	5.16	5.11	5.37	7.80	7.41
Others Liabilities ⓘ	0.56	0.74	0.15	6.23	2.90	0.47	3.94	-1.26	5.07	3.65
Total Liabilities ⓘ	22.78	26.38	41.03	52.71	52.64	50.74	52.61	52.11	53.39	54.67
Fixed Assets
Gross Block	18.49	18.74	14.47	20.02	24.24	25.72	25.72	25.74	26.76	27.06
Accumulated Depreciation	7.77	8.78	1.02	2.35	3.71	5.06	5.79	6.41	7.02	7.74
Net Fixed Assetsⓘ	10.73	9.96	13.46	17.67	20.52	20.66	19.93	19.33	19.74	19.32
CWIP ⓘ	0	0	1.99	7.11	8.54	8.78	9.08	9.08	9.33	9.82
Investmentsⓘ	0	0	0	0.02	0.03	0.02	0.04	0.03	0.02	0.02
Inventories	0.22	2.68	8.14	10.91	11.25	9.68	9.68	9.33	7.68	6.79
Trade Receivables	11.29	9.74	9.01	10.86	8.35	10.28	2.17	10.46	11.25	14.28
Cash Equivalents	0.10	0.43	5.77	1.79	0.87	0.23	0.14	0.07	0.20	0.09
Others Assetsⓘ	0.44	3.57	2.65	4.36	3.08	1.09	11.56	3.80	5.17	4.35
Total Assets ⓘ	22.78	26.38	41.03	52.71	52.64	50.74	52.61	52.11	53.39	54.67

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-3.53	-2.50	2.57	-4.58	3.30	0.80	-6.75	-0.99	-1.71	-4.91
PBT ⓘ	1.26	0.84	1.22	2.83	1.15	-3.94	-3.69	-2.62	-5.88	-5.18
Adjustment ⓘ	1.45	1.78	1.88	2.61	2.03	1.91	2.25	1.51	1.83	1.94
Changes in Working Capital ⓘ	-6.24	-4.93	-0.52	-10.03	0.5	2.83	-5.31	0.12	1.28	-1.68
Tax Paid ⓘ	0	-0.18	0	0	-0.38	0	0	0	1.05	0
Cash Flow From Investing Activity ⓘ	-0.09	-0.24	-3.61	-10.61	-5.65	-1.73	-0.30	-0.01	-1.27	-0.79
Capex	-0.10	-0.25	-3.64	-10.66	-5.65	-1.73	-0.30	-0.01	-1.27	-0.79
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.01	0.01	0.03	0.05	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	3.63	3.07	6.36	11.22	1.43	0.28	6.96	0.94	3.11	5.59
Net Proceeds from Shares ⓘ	0	0	3.78	7.49	0.24	0	9	0	0.76	9.61
Net Proceeds from Borrowing ⓘ	0	7.88	6.03	-0.15	0.07	-0.45	3.19	0.67	-2.25	-2.25
Interest Paid ⓘ	-0.41	-0.77	-0.88	-1.57	-1.67	-1.54	-1.55	-0.90	-1.21	-1.22
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	4.04	-4.04	-2.57	5.45	2.79	2.27	-3.68	1.16	5.81	-0.55
Net Cash Flow ⓘ	0	0.34	5.32	-3.98	-0.92	-0.64	-0.09	-0.07	0.13	-0.11

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	13.94	7.15	8.97	10.19	3.15	-11.68	-6.43	-2.6	-17.16	-13.63
ROCE (%)	14.16	9.57	8.92	12.42	6.28	-5.2	-5.1	-3.75	-9.58	-8.28
Asset Turnover Ratio	0.75	0.63	0.72	0.62	0.59	0.44	0.02	0.01	0.02	0.19
PAT to CFO Conversion(x)	-2.6	-3.25	2.06	-2.09	3.51	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	164	250	142	125	113	149	1,794	5,843	3,948	453
Inventory Days	12	34	82	120	130	168	2,790	8,792	3,092	257
Payable Days	299	273	221	252	103	83	2,566	5,213	850	312

Vista Pharmaceuticals Ltd Stock News

Vista Pharmaceuticals Ltd FAQs

What is the share price of Vista Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Vista Pharma on 30-Apr-2025 16:59 is ₹10.85.

What is the market cap of Vista Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 30-Apr-2025 16:59 the market cap of Vista Pharma stood at ₹63.20.

What is the P/E ratio of Vista Pharma?

The latest P/E ratio of Vista Pharma as of 30-Apr-2025 16:59 is 0.00.

What is the P/B ratio of Vista Pharma?

The latest P/B ratio of Vista Pharma as of 30-Apr-2025 16:59 is 1.37.

What is the 52-week high and low of Vista Pharma?

The 52-week high of Vista Pharma is ₹16.59 and the 52-week low is ₹9.10.

What is the TTM revenue of Vista Pharma?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vista Pharma is ₹9.98 ( Cr.) .

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.

The Company was in process of setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.

Vista, the largest division of Torrent Pharmaceuticals Ltd, offers a range of products mainly in the therapeutic areas of gastrointestinal, pain management and anti-infective, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd.